Press Releases - 2023-08-15

Date	Title	Company
15-Aug-2023	Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS	Businesswire
15-Aug-2023	Now 70+ Senior Level Speakers on the Updated Agenda	Pharma CI Conference
15-Aug-2023	Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment	Businesswire
15-Aug-2023	Cyclo Therapeutics Reports Second Quarter 2023 Financial Results	Businesswire
15-Aug-2023	BioscienceLA Launches Leadership Catalyst Program For Emerging Leaders in the Life Sciences	Businesswire
15-Aug-2023	ExThera Medical Receives Certification for Medical Device Single Audit Program (MDSAP) and Recertification for International Organization for Standardization for Medical Devices (ISO 13485)	Businesswire
15-Aug-2023	SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy	Businesswire
15-Aug-2023	AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors	Businesswire
15-Aug-2023	Boston Micro Fabrication to Market World’s Thinnest Cosmetic Dental Veneer	Businesswire
15-Aug-2023	Younger Generations: Key Drivers of the Global Blood Plasma Market in 2023 - Insights on Immunoglobulins, Coagulation Factors, and Albumin-derived Therapies - ResearchAndMarkets.com	Businesswire
15-Aug-2023	Annovis Bio Announces Second Quarter 2023 Financial Results and Provides Corporate Update	Businesswire
15-Aug-2023	Systech Receives Prestigious Certifications	Businesswire
15-Aug-2023	Fluree Announces Partnership with Vitality TechNet to Enable Pharmaceutical Regulatory Information Management and Accelerate Drug Discovery	Businesswire
15-Aug-2023	Venatorx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI), including Pyelonephritis, in Adults	Businesswire
15-Aug-2023	Wugen Begins First-in-Human Phase 1 Clinical Trial of WU-NK-101, its Lead Allogeneic Memory Natural Killer (NK) Cell Therapy for Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)	Businesswire
15-Aug-2023	Ryder Secures Spot Among Supply & Demand Chain Executive’s ‘Top Supply Chain Projects’	Businesswire
15-Aug-2023	Bios Health Group Enters the Market to Offer Investment-Driven and Clinical Development Optimization Strategies for Biotech and Life Science Companies	Bios Health Group
15-Aug-2023	Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software	Refeyn
15-Aug-2023	Key Enzyme for Drug Metabolism Exhibits Soft Robotic Properties Which Could Lead to Advanced Biogels and Polymers, According to Hebrew University Researchers	Hebrew University of Jerusalem (HU)
15-Aug-2023	Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom	Amicus Therapeutics